该公司主要从事骨科和脊柱生物学领域。它提供固定系统和生物学产品,旨在治疗脊柱和骨科疾病。
排他性优势:
1. 拥有强大的研发能力,能不断开发和推出创新产品,如新的固定系统和生物学产品。
2. 构建了一个互补的产品组合,包括固定和生物学解决方案,能...查看全文
$Xtant医控股(XTNT)$ S-3 Registration statement under Securities Act of 1933 Accession Number: 0001493152-22-028120 Act: 33 Size: 409 KB 网页链接
$Xtant医控股(XTNT)$ 8-K Current report, items 3.02, 7.01, and 9.01 Accession Number: 0001493152-22-028040 Act: 34 Size: 249 KB 网页链接
$Xtant医控股(XTNT)$ DEF 14A Other definitive proxy statements Accession Number: 0001493152-22-026308 Act: 34 Size: 1 MB 网页链接
$Xtant医控股(XTNT)$ DEF 14C Other definitive information statements Accession Number: 0001493152-22-025444 Act: 34 Size: 291 KB 网页链接
$Xtant医控股(XTNT)$ SC 13D General statement of acquisition of beneficial ownership Accession Number: 0001104659-22-097801 Act: 34 Size: 59 KB 网页链接
$Xtant医控股(XTNT)$ 8-K Current report, items 3.02, 5.02, 7.01, 8.01, and 9.01 Accession Number: 0001493152-22-024444 Act: 34 Size: 706 KB 网页链接
$Xtant医控股(XTNT)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0000947871-22-000940 Act: 34 Size: 103 KB 网页链接
$Xtant医控股(XTNT)$ PRE 14C Other preliminary information statements Accession Number: 0001493152-22-024393 Act: 34 Size: 284 KB 网页链接
$Xtant医控股(XTNT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001235802-22-000107 Size: 5 KB 网页链接
$Xtant医控股(XTNT)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001235802-22-000106 Size: 9 KB 网页链接